Your account is not claimed yet. You can sign up with ORCID to claim your account.

Isabel Barragán (Isabel Barragan, I Barragán)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Venues

British journal of cancer

Biomedicines

Cancers

Cell death discovery

Instituto de Investigación Biomédica de Málaga

Universidad de Sevilla (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Instituto de Investigación Biomédica de Málaga Mar 1o 2020

Spain

Pharmacologist and Geneticist. Nicolas Monardes Programme Senior Researcher, Group Leader. :: Medical Oncology Unit Intercentros

Education History

Universidad de Sevilla Oct 1o 2001 - Jun 27o 2007

Spain

PHD

Publications

Patricia Chaves, María Garrido, Javier Oliver, Elisabeth Perez-Ruiz, Isabel Barragán, Antonio Rueda-Domínguez
Preclinical models in head and neck squamous cell carcinoma. British journal of cancer (2023)
Patricia Chaves, María Garrido, Javier Oliver, Elisabeth Perez-Ruiz, Isabel Barragán, Antonio Rueda-Domínguez
Preclinical models in head and neck squamous cell carcinoma. British journal of cancer (2023)
Patricia Chaves, María Garrido, Javier Oliver, Elisabeth Perez-Ruiz, Isabel Barragán, Antonio Rueda-Domínguez
Preclinical models in head and neck squamous cell carcinoma. British journal of cancer (2023)
Javier Oliver, Juan-Luis Onieva-Zafra, María Garrido-Barros, Manuel Cobo, Beatriz Martínez-Gálvez, Ana Isabel García-Pelícano, Jaime Dubbelman, José Carlos Benítez, Juan Zafra Martín, Alejandra Cantero, Elisabeth Perez-Ruiz, Antonio Rueda Domínguez, Isabel Barragán
Fluorometric Quantification of Total Cell-Free DNA as a Prognostic Biomarker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade. Cancers 15 (13) (2023)
Miguel-Angel Berciano-Guerrero, Mora Guardamagna, Elisabeth Perez-Ruiz, Jose-Miguel Jurado, Isabel Barragán, Antonio Rueda-Dominguez
Treatment of Metastatic Melanoma at First Diagnosis: Review of the Literature. Life (Basel, Switzerland) 12 (9) (2022)
Javier Oliver, Juan-Luis Onieva-Zafra, Maria Garrido-Barros, Miguel-Angel Berciano-Guerrero, Alfonso Sánchez-Muñoz, María José Lozano, Angela Farngren, Martina Alvarez, Beatriz Martínez-Gálvez, Elisabeth Perez-Ruiz, Emilio Alba, Manuel Cobo, Antonio Rueda-Domínguez, Isabel Barragán
Association of Circular RNA and Long Non-Coding RNA Dysregulation with the Clinical Response to Immune Checkpoint Blockade in Cutaneous Metastatic Melanoma. Biomedicines 10 (10) (2022)
Jonas Nørskov Søndergaard, Christian Sommerauer, Ionut Atanasoai, Laura C Hinte, Keyi Geng, Giulia Guiducci, Lars Bräutigam, Myriam Aouadi, Lovorka Stojic, Isabel Barragán, Claudia Kutter
CCT3- LINC00326 axis regulates hepatocarcinogenic lipid metabolism. Gut (2022)
Mora Guardamagna, Miguel-Angel Berciano-Guerrero, Beatriz Villaescusa-González, Elisabeth Perez-Ruiz, Javier Oliver, Rocío Lavado-Valenzuela, Antonio Rueda Domínguez, Isabel Barragán, María Isabel Queipo-Ortuño
Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition. International journal of molecular sciences 23 (19) (2022)
Elisabeth Perez-Ruiz, Vanesa Gutiérrez, Marta Muñoz, Javier Oliver, Marta Sánchez, Laura Gálvez-Carvajal, Antonio Rueda-Domínguez, Isabel Barragán
Liquid Biopsy as a Tool for the Characterisation and Early Detection of the Field Cancerization Effect in Patients with Oral Cavity Carcinoma. Biomedicines 9 (10) (2021)
Jessica Gasca, M L Flores, Rocío Jiménez-Guerrero, María Eugenia Sáez, Isabel Barragán, M Ruíz-Borrego, M Tortolero, Francisco Romero, Carmen Saez, Miguel A Japón
EDIL3 promotes epithelial-mesenchymal transition and paclitaxel resistance through its interaction with integrin αVβ3 in cancer cells. Cell death discovery 6 (2020)

Isabel Barragán.css-eqlu8i{font-size:small;padding-left:4px;} (Isabel Barragan, I Barragán)

Publication Activity (10 Years)

Top Topics

Top Venues

Isabel Barragán (Isabel Barragan, I Barragán)